三博脑科：公司SEEG电极植入手术量及有效率均处于全国先进水平

Core Viewpoint - The company Sanbo Brain Science has successfully introduced advanced surgical equipment for epilepsy electrode implantation, indicating a strong position in the market and a growing revenue stream from its medical services [2]. Group 1: Technology and Innovation - Sanbo Brain Science was the first in the country to introduce ROSA surgical equipment in 2012 and its second-generation ROSA ONE for SEEG electrode implantation in 2020, showcasing its commitment to innovation in neurosurgery [2]. - The company reports that its SEEG electrode implantation procedures and success rates are at an advanced level nationally, reflecting its technological leadership [2]. Group 2: Revenue and Business Model - The primary revenue source for Sanbo Brain Science comes from the medical services provided by its affiliated hospitals, indicating a reliance on operational growth in healthcare services [2]. - There is a trend of increasing neurosurgery procedure volumes, suggesting a positive outlook for the company's financial performance [2].